Reuters logo
BRIEF-Moody's Says Pharma Manufacturers, Distributors Face Rising Risks Related To U.S. Opioid Crisis
November 30, 2017 / 3:19 PM / 17 days ago

BRIEF-Moody's Says Pharma Manufacturers, Distributors Face Rising Risks Related To U.S. Opioid Crisis

Nov 30 (Reuters) - Moody‘s:

* MOODY‘S SAYS PHARMA MANUFACTURERS AND DISTRIBUTORS FACE RISING RISKS RELATED TO U.S. OPIOID CRISIS

* MOODY‘S ON U.S. OPIOID CRISIS - BRANDED,GENERIC DRUG COS,DRUG DISTRIBUTORS WILL BE INCREASINGLY EXPOSED TO DECLINING PRODUCT SALES, RISING LEGAL RISKS

* MOODY‘S SAYS ABILITY OF PHARMA MANUFACTURERS,DISTRIBUTORS TO FACE RISKS RELATED TO U.S. OPIOID CRISIS WILL DEPEND ON SCALE,DIVERSITY,LIQUIDITY, OTHERS

* MOODY‘S SAYS AMONG COS,J&J IS SUFFICIENTLY STRONG TO ABSORB U.S. OPIOID-RELATED RISKS, WHILE ENDO PHARMACEUTICALS & TEVA HAVE MORE LIMITED FLEXIBILITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below